Dental pulp-derived CD31-/CD146- side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats

Masahiko Sugiyama, Koichiro Iohara, Hideaki Wakita, Hisashi Hattori, Minoru Ueda, Kenji Matsushita, Misako Nakashima

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Regenerative therapy using stem cells is a promising approach for the treatment of stroke. Recently, we reported that CD31-/CD146 - side population (SP) cells from porcine dental pulp exhibit highly vasculogenic potential in hindlimb ischemia. In this study, we investigated the influence of CD31-/CD146- SP cells after transient middle cerebral artery occlusion (TMCAO). Adult male Sprague-Dawley rats were subjected to 2 h of TMCAO. Twenty-four hours after TMCAO, CD31-/CD146 - SP cells were transplanted into the brain. Motor function and infarct volume were evaluated. Neurogenesis and vasculogenesis were determined with immunochemical markers, and the levels of neurotrophic factors were assayed with real-time reverse transcription-polymerase chain reaction. In the cell transplantation group, the number of doublecortin-positive cells increased twofold, and the number of NeuN-positive cells increased eightfold, as compared with the control phosphate-buffered saline group. The vascular endothelial growth factor level in the ischemic brain with transplanted cells was 28 times higher than that in the normal brain. In conclusion, CD31-/CD146 - SP cells promoted migration and differentiation of the endogenous neuronal progenitor cells and induced vasculogenesis, and ameliorated ischemic brain injury after TMCAO.

Original languageEnglish
Pages (from-to)1303-1311
Number of pages9
JournalTissue Engineering - Part A
Volume17
Issue number9-10
DOIs
Publication statusPublished - 01-05-2011

Fingerprint

Side-Population Cells
Dental Pulp
Middle Cerebral Artery Infarction
Stem cells
Brain Ischemia
Pulp
Rats
Brain
Stem Cells
Recovery
Cells
Polymerase chain reaction
Cell Transplantation
Neurogenesis
Nerve Growth Factors
Transcription
Hindlimb
Brain Injuries
Vascular Endothelial Growth Factor A
Reverse Transcription

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Cite this

Sugiyama, Masahiko ; Iohara, Koichiro ; Wakita, Hideaki ; Hattori, Hisashi ; Ueda, Minoru ; Matsushita, Kenji ; Nakashima, Misako. / Dental pulp-derived CD31-/CD146- side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats. In: Tissue Engineering - Part A. 2011 ; Vol. 17, No. 9-10. pp. 1303-1311.
@article{f387c4c0cdab4812a479de6c1b250ee8,
title = "Dental pulp-derived CD31-/CD146- side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats",
abstract = "Regenerative therapy using stem cells is a promising approach for the treatment of stroke. Recently, we reported that CD31-/CD146 - side population (SP) cells from porcine dental pulp exhibit highly vasculogenic potential in hindlimb ischemia. In this study, we investigated the influence of CD31-/CD146- SP cells after transient middle cerebral artery occlusion (TMCAO). Adult male Sprague-Dawley rats were subjected to 2 h of TMCAO. Twenty-four hours after TMCAO, CD31-/CD146 - SP cells were transplanted into the brain. Motor function and infarct volume were evaluated. Neurogenesis and vasculogenesis were determined with immunochemical markers, and the levels of neurotrophic factors were assayed with real-time reverse transcription-polymerase chain reaction. In the cell transplantation group, the number of doublecortin-positive cells increased twofold, and the number of NeuN-positive cells increased eightfold, as compared with the control phosphate-buffered saline group. The vascular endothelial growth factor level in the ischemic brain with transplanted cells was 28 times higher than that in the normal brain. In conclusion, CD31-/CD146 - SP cells promoted migration and differentiation of the endogenous neuronal progenitor cells and induced vasculogenesis, and ameliorated ischemic brain injury after TMCAO.",
author = "Masahiko Sugiyama and Koichiro Iohara and Hideaki Wakita and Hisashi Hattori and Minoru Ueda and Kenji Matsushita and Misako Nakashima",
year = "2011",
month = "5",
day = "1",
doi = "10.1089/ten.tea.2010.0306",
language = "English",
volume = "17",
pages = "1303--1311",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "9-10",

}

Dental pulp-derived CD31-/CD146- side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats. / Sugiyama, Masahiko; Iohara, Koichiro; Wakita, Hideaki; Hattori, Hisashi; Ueda, Minoru; Matsushita, Kenji; Nakashima, Misako.

In: Tissue Engineering - Part A, Vol. 17, No. 9-10, 01.05.2011, p. 1303-1311.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dental pulp-derived CD31-/CD146- side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats

AU - Sugiyama, Masahiko

AU - Iohara, Koichiro

AU - Wakita, Hideaki

AU - Hattori, Hisashi

AU - Ueda, Minoru

AU - Matsushita, Kenji

AU - Nakashima, Misako

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Regenerative therapy using stem cells is a promising approach for the treatment of stroke. Recently, we reported that CD31-/CD146 - side population (SP) cells from porcine dental pulp exhibit highly vasculogenic potential in hindlimb ischemia. In this study, we investigated the influence of CD31-/CD146- SP cells after transient middle cerebral artery occlusion (TMCAO). Adult male Sprague-Dawley rats were subjected to 2 h of TMCAO. Twenty-four hours after TMCAO, CD31-/CD146 - SP cells were transplanted into the brain. Motor function and infarct volume were evaluated. Neurogenesis and vasculogenesis were determined with immunochemical markers, and the levels of neurotrophic factors were assayed with real-time reverse transcription-polymerase chain reaction. In the cell transplantation group, the number of doublecortin-positive cells increased twofold, and the number of NeuN-positive cells increased eightfold, as compared with the control phosphate-buffered saline group. The vascular endothelial growth factor level in the ischemic brain with transplanted cells was 28 times higher than that in the normal brain. In conclusion, CD31-/CD146 - SP cells promoted migration and differentiation of the endogenous neuronal progenitor cells and induced vasculogenesis, and ameliorated ischemic brain injury after TMCAO.

AB - Regenerative therapy using stem cells is a promising approach for the treatment of stroke. Recently, we reported that CD31-/CD146 - side population (SP) cells from porcine dental pulp exhibit highly vasculogenic potential in hindlimb ischemia. In this study, we investigated the influence of CD31-/CD146- SP cells after transient middle cerebral artery occlusion (TMCAO). Adult male Sprague-Dawley rats were subjected to 2 h of TMCAO. Twenty-four hours after TMCAO, CD31-/CD146 - SP cells were transplanted into the brain. Motor function and infarct volume were evaluated. Neurogenesis and vasculogenesis were determined with immunochemical markers, and the levels of neurotrophic factors were assayed with real-time reverse transcription-polymerase chain reaction. In the cell transplantation group, the number of doublecortin-positive cells increased twofold, and the number of NeuN-positive cells increased eightfold, as compared with the control phosphate-buffered saline group. The vascular endothelial growth factor level in the ischemic brain with transplanted cells was 28 times higher than that in the normal brain. In conclusion, CD31-/CD146 - SP cells promoted migration and differentiation of the endogenous neuronal progenitor cells and induced vasculogenesis, and ameliorated ischemic brain injury after TMCAO.

UR - http://www.scopus.com/inward/record.url?scp=79955046660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955046660&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2010.0306

DO - 10.1089/ten.tea.2010.0306

M3 - Article

C2 - 21226624

AN - SCOPUS:79955046660

VL - 17

SP - 1303

EP - 1311

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 9-10

ER -